CRYSTAL PEEL
Texto original en francés.
Producto de salud natural autorizado en Canadá
- Otros nombres
- Superficial Chemical Peel
- Titular
- 2625686 ONTARIO INC dba NUVIOR
- NPN o DIN-HM
- 80124648
- Estado
- Licencia activa
- Fecha de licencia
- 25 de mayo de 2023
- Fecha de revisión
- No indicada
- Forma
- Liquide topique
- Vía de administración
- Topique
- Tipo de solicitud
- Générale (non traditionelle)
El análisis de dosis orales no se aplica sin una vía exclusivamente oral establecida.
Composición
| Ingrediente medicinal y fuente | Por unidad posológica, según la fuente |
|---|---|
| Acide 2-hydroxybenzoïque Fuente : Acide salicylique | 20 % (v/v) |
Ingredientes no medicinales
Acide phosphorique, Eau, SD alcool 40-A
Dosis recomendadas en Canadá
| Población | Edad | Cantidad por toma | Frecuencia |
|---|---|---|---|
| Adultes | minimum : 18 ans | Non précisée | Non précisée |
Usos autorizados en Canadá
Acne treatment. Intended for the treatment of Mild Acne & Hyperkeratosis. Intended for the treatment of Melasma, solar and senile lentigines and post inflammatory pigmentation.
Texto original en inglés.
Un uso autorizado en Canadá no es una declaración de propiedades saludables autorizada en la Unión Europea. Consulte el registro de declaraciones de propiedades saludables.
Advertencias en Canadá
Known Adverse Reactions : Allergy alert get medical help right away if the patient develops hives, swelling of eyes and mouth, blistering, or difficulty breathing. Stop use if patient develops severe irritation, burning/itching of the skin, pigmentation, or milia. Use with caution in patients who have a recent history of smoking, herpes simplex, dermatitis, psoriasis, or any other inflammatory condition in the skin area to be treated Use with caution in patients who suffer from immunosuppression, or are taking oral contraceptives or tetracyclines Use with caution in patients who have recently had medical or cosmetic treatment or procedure (e.g., laser therapy, surgical procedures, cosmetic filler, microdermabrasion, etc.) Do not use on inflamed, broken or infected skin. Do not use in patients with vitiligo, diabetes, active cold sores, or poor blood circulation, or who currently suffer from any type of infection Do not apply to large areas of the body. Do not apply under occlusion (as this may cause salicylism, characterized by tinnitus, dizziness, abdominal cramps, and deafness) Do not use if patient is allergic to acetylsalicylic acid or other salicylates.
Texto original en inglés.
Cautions and Warnings : For external use only. Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away. When using this product skin irritation and dryness are more likely to occur when using another topical acne product at the same time. If irritation occurs, use only one product at a time. When using this product, avoid contact with eyes. If contact occurs, rinse thoroughly with water. Avoid contact with mucous membranes such as nose and lips; protect these sensitive areas with a moisturizer or petrolatum-based agent. In case of contact, rinse thoroughly with water. If irritation persists, discontinue use and seek medical attention. Do not use on an irritated area, facial herpes, skin allergy or after taking retinoids (or any potentially irritating substance), eye contour and perioral area. Consult a health care practitioner if symptoms persist or worsen. Skin contact should be of limited frequency and duration. One week before the treatment, do not perform hair removal or electrolysis on the area to be treated. Four hours before the treatment, do not shave the affected area. The use of depilatory agents, waxes, depilatory lasers, exfoliating sponges and masks must be discontinued one week before the treatment. For Professional use only. Not for Retail Sale. Please limit sun exposure and apply a sunburn protectant for a week after using this product
Texto original en inglés.
Contra-Indications : Do not use in patients who are pregnant or breastfeeding. Use with caution in patients who have HIV or have undergone treatment with dermabrasion or ablative resurfacing within the past 12 months. Do not use if the patient suffers from flat warts, or from a viral dermatological infection such as molloscum contagiosum. Do not use in patients who have taken isotretinoin in the past 12 months, have received recent chemotherapy or radiation therapy, or are taking photosensitizing medication. These side effects are frequently observed: burning, dermatitis, blisters, redness, swelling, itching, peeling, rash, dryness and skin lesions.
Texto original en inglés.
Fuente
Ficha oficial de Health Canada, licencia 80124648
Base de datos de productos de salud natural autorizados (BDPSNH), Health Canada: productos autorizados, ingredientes, dosis, usos y advertencias, consultado el 27 de octubre de 2026.
Contient des informations visées par la Licence du gouvernement ouvert – Canada (Santé Canada, BDPSNH)
Texto original en francés.
Texto original en francés.
La fórmula vendida en Europa con el mismo nombre puede ser diferente. Esta información no sustituye el consejo de un médico o farmacéutico.
Se desconoce la fecha de la prueba de esta lista de ingredientes.
¿Ha cambiado el producto? Fotografíe el envase.